Privia Health Group, Inc. (PRVA) vs 10x Genomics (TXG)
- Privia Health Group, Inc. PRVA 22.46 −0.71%
- 10x Genomics TXG 69.86 −3.49%
Privia Health Group, Inc. and 10x Genomics are both Health Information Services companies. 10x Genomics is the larger, with a market value of $9.4B against $2.9B — 3.3× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Privia Health Group, Inc. trades at 102×. Privia Health Group, Inc. grew revenue faster over the last twelve months: 24.1% against −4.28%. Privia Health Group, Inc. has the higher net margin (1.19% vs −12.2%) and the higher return on invested capital (6.59% vs −20.2%). Across the 19 metrics below, Privia Health Group, Inc. leads on 14 and 10x Genomics on 5.
Valuation
Profitability
| Metric | PRVA | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 10.03% | 70.03% | 62.87% |
| Operating margin | 1.90% | (14.33%) | (9.45%) |
| Net margin | 1.19% | (12.18%) | (15.48%) |
| Free cash flow margin | 5.56% | 19.68% | 0.00% |
| Return on equity | 3.58% | (9.40%) | (6.91%) |
| Return on assets | 2.04% | (7.47%) | (6.28%) |
| Return on invested capital | 6.59% | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack